Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Idera Pharmaceuticals Inc (IDRA)
Idera Pharmaceuticals Inc (IDRA) News

IDRA

Idera Pharmaceuticals (IDRA)

Idera Pharmaceuticals Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IDRA

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next >>

Date	Time	Source	Headline	Symbol	Company
12/20/2018	5:29PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
12/20/2018	5:29PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
12/20/2018	5:27PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
12/20/2018	5:23PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
12/18/2018	4:18PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
12/18/2018	4:05PM	GlobeNewswire Inc.	Idera Pharmaceuticals Announces Appointment of Carol A. Schafer to its Board of Directors	NASDAQ:IDRA	Idera Pharmaceuticals Inc
12/14/2018	7:08AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
12/14/2018	7:00AM	GlobeNewswire Inc.	Idera Pharmaceuticals Presents Clinical Safety and Efficacy Update from the ILLUMINATE-204 Trial of the Combination of Tilsot...	NASDAQ:IDRA	Idera Pharmaceuticals Inc
12/12/2018	4:01PM	GlobeNewswire Inc.	Idera Pharmaceuticals to Provide ILLUMINATE-204 Clinical Data Update on Friday, December 14, 2018	NASDAQ:IDRA	Idera Pharmaceuticals Inc
11/26/2018	5:28PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
11/26/2018	5:26PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
11/06/2018	5:35PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
11/06/2018	4:51PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
11/06/2018	4:30PM	GlobeNewswire Inc.	Idera Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update	NASDAQ:IDRA	Idera Pharmaceuticals Inc
11/02/2018	5:44PM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
11/02/2018	5:38PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
11/02/2018	8:33AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
10/19/2018	6:00AM	GlobeNewswire Inc.	Idera Pharmaceuticals Presents Data from the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Unres...	NASDAQ:IDRA	Idera Pharmaceuticals Inc
09/20/2018	5:34PM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
09/20/2018	5:13PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
09/20/2018	5:11PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
09/19/2018	9:17AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
09/18/2018	4:01PM	GlobeNewswire Inc.	Idera Pharmaceuticals Announces Appointment of Howard Pien to its Board of Directors	NASDAQ:IDRA	Idera Pharmaceuticals Inc
09/13/2018	4:23PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
09/13/2018	4:21PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
09/13/2018	4:10PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
09/11/2018	7:00AM	GlobeNewswire Inc.	Idera Pharmaceuticals Announces Corporate Organizational Changes	NASDAQ:IDRA	Idera Pharmaceuticals Inc
09/04/2018	4:42PM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
09/04/2018	2:56PM	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:IDRA	Idera Pharmaceuticals Inc
08/30/2018	7:30AM	GlobeNewswire Inc.	Idera Pharmaceuticals to Present at the H.C. Wainwright 20th Annual Global Investment Conference	NASDAQ:IDRA	Idera Pharmaceuticals Inc

Showing the most relevant articles for your search:NASDAQ:IDRA

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next >>

Marketing Worldwide (PK)

Bell Buckle (PK)

Virexit Technologies (PK)

Canopus Biopharma (PK)

Seafarer Exploration (PK)

NioCorp Developments

Brookmount Explorations (PK)

Decentral Life (PK)

Seven Arts Entertainment (PK)

Ubiquitech Software (PK)

Fannie Mae (QB)

Gold and GemStone Mining (PK)

Anavex Life Sciences

Delayed Upgrade Clock